Boston Scientific (BSX) Tops Q3 EPS by 1c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St indexes fall to two-week lows as rising bond yields, disappointing Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Boston Scientific (BSX) Top Rating Maintained at Needham & Company Despite Mixed Qtr
October 24, 2018 12:52 PM EDTNeedham & Company analyst Mike Matson reiterated a Strong Buy and $43 price target on Boston Scientific (NYSE: BSX) as revenue missed consensus due to currency while its EPS beat consensus. Meanwhile, management lowered its revenue guidance due to currency and narrowed its EPS guidance.
Matson... More
